Balance Sheet Data

Bristol-Myers Squibb Company (BMY)

$81.13

+0.25 (+0.31%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 6,8128,88415,39316,45017,22123,805.1429,530.0536,631.7645,441.3556,369.57
Total Cash (%)
Account Receivables 6,3005,9657,6858,50112,51615,321.0319,005.6023,576.2729,246.1436,279.56
Account Receivables (%)
Inventories 1,1661,1954,2932,0742,0954,226.155,242.496,503.268,067.2410,007.33
Inventories (%)
Accounts Payable 2,2481,8922,4452,7132,9494,752.425,895.337,313.109,071.8311,253.52
Accounts Payable (%)
Capital Expenditure -1,055-951-836-753-973-1,882.65-2,335.41-2,897.05-3,593.77-4,458.04
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.